Zoetis™ Celebrates Initial Public Offering and First Day of Trading on the New York Stock Exchange

  Zoetis™ Celebrates Initial Public Offering and First Day of Trading on the
  New York Stock Exchange

Business Wire

NEW YORK -- February 1, 2013

Zoetis, a leading animal health company, opened for trading today on the New
York Stock Exchange (NYSE) under the ticker symbol “ZTS” after its initial
public offering. Barclays is the Designated Market Maker (DMM) for the
company’s stock. CEO Juan Ramón Alaix, joined by members of the Zoetis team,
celebrated the company’s first day of trading by visiting the NYSE trading
floor for the stock opening and by ringing The Opening Bell.

Zoetis Chief Executive Officer Juan Ramon Alaix, joined by members of the
Zoetis team, rings the NYS ...

Zoetis Chief Executive Officer Juan Ramon Alaix, joined by members of the
Zoetis team, rings the NYSE Opening Bell to celebrate the company's IPO and
first day of trading on the NYSE. (Source: NYSE Euronext Photo)

"We welcome Zoetis to our growing community of listed companies,” said Scott
Cutler, Executive Vice President, Head of Global Listings, NYSE Euronext. “As
the largest standalone company in animal health, Zoetis supports veterinarians
and livestock producers around the world with innovative medicines and
vaccines that help them raise and care for animals. We congratulate Zoetis as
they embark upon this new chapter and look forward to a long-standing
partnership with the company and its shareholders.”

For more information on NYSE Euronext’s Listings business and to learn about
trends in the IPO market, please visit the NYSE Euronext IPO Center.

About Zoetis (NYSE: ZTS)

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on a 60-year history
as the animal health business of Pfizer, Zoetis discovers, develops,
manufactures and markets veterinary vaccines and medicines, with a focus on
both farm and companion animals. The company generated annual revenue of $4.2
billion in fiscal 2011. Zoetis has more than 9,500 employees and a local
presence in approximately 70 countries, including 29 manufacturing facilities
in 11 countries. Its products serve veterinarians, livestock producers and
people who raise and care for farm and companion animals in 120 countries.
(Source: Zoetis)

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and
provider of innovative trading technologies. The company's exchanges in Europe
and the United States trade equities, futures, options, fixed-income and
exchange-traded products. With approximately 8,000 listed issues (excluding
European Structured Products), NYSE Euronext's equities markets - the New York
Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most liquidity of any
global exchange group. NYSE Euronext also operates NYSE Liffe, one of the
leading European derivatives businesses and the world's second-largest
derivatives business by value of trading. The company offers comprehensive
commercial technology, connectivity and market data products and services
through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130201005638/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50550850&lang=en

Contact:

NYSE Media Relations
Annmarie Gioia, 212-656-5437
agioia@nyx.com
 
Press spacebar to pause and continue. Press esc to stop.